Home › Smoldering Multiple Myeloma › Utah
Smoldering Multiple Myeloma clinical trials in Utah
3 studies for Smoldering Multiple Myeloma are looking for participants at sites in Utah.
Cities in Utah
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
- Huntsman Cancer Institute/University of Utah, Salt Lake City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT03937635Smoldering Myeloma High-Risk Patient Observation and Longitudinal Insight Trial
- Huntsman Cancer Institute at the University of Utah, Salt Lake City
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06212323Screening for AL Amyloidosis in Smoldering Multiple Myeloma
- University of Utah, Huntsman Cancer Hospital, Salt Lake City
RecruitingObservational study
Ages 40 and older · All sexes · Updated Aug 6, 2025 · NCT06365060From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.